+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Insulin Market Size, Share & Trends Analysis by Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilar), by Application, by Type (Type 1, Type 2), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Insulin Market Size, Share & Trends Analysis by Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilar), by Application, by Type (Type 1, Type 2), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030

  • Report
  • July 2022
  • 150 Pages
  • Global
From
Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 - Product Thumbnail Image

Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

  • Report
  • January 2023
  • 127 Pages
  • Global
From
Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025) - Product Thumbnail Image

Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

  • Report
  • April 2021
  • Global
From
United States Smart Insulin Pen Market and Forecast 2021-2027 - Product Thumbnail Image

United States Smart Insulin Pen Market and Forecast 2021-2027

  • Report
  • October 2021
  • 45 Pages
  • United States
From
United States Insulin Delivery Devices Market Size, Analysis, Insights, Trends, Share Outlook, Opportunities, Companies and Forecasts up to 2027 - Product Thumbnail Image

United States Insulin Delivery Devices Market Size, Analysis, Insights, Trends, Share Outlook, Opportunities, Companies and Forecasts up to 2027

  • Report
  • October 2021
  • 180 Pages
  • United States
From
United States Diabetes Insulin Delivery Pen Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026 - Product Thumbnail Image

United States Diabetes Insulin Delivery Pen Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026

  • Report
  • March 2019
  • 80 Pages
  • United States
From
Jardiance - Product Thumbnail Image

Jardiance

  • Drug Pipelines
  • February 2019
  • 43 Pages
  • Global
From
Drug Analysis: Invokana - Product Thumbnail Image

Drug Analysis: Invokana

  • Drug Pipelines
  • February 2018
  • 33 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Bisphosphonates, Vitamin D3), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Bisphosphonates, Vitamin D3), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), And Segment Forecasts, 2023 - 2030

  • Report
  • May 2023
  • 180 Pages
  • Global
From
Metabolic Disorders Drugs Global Market Report 2022, By Type, Drug Type, Distribution Channel, Route Of Administration, Drug Classification, Mode Of Purchase - Product Thumbnail Image

Metabolic Disorders Drugs Global Market Report 2022, By Type, Drug Type, Distribution Channel, Route Of Administration, Drug Classification, Mode Of Purchase

  • Report
  • March 2022
  • 300 Pages
  • Global
From
Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025 - Product Thumbnail Image

Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025

  • Report
  • August 2020
  • 250 Pages
  • Saudi Arabia
From
Cell Therapies for Type I Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment - Product Thumbnail Image

Cell Therapies for Type I Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment

  • Report
  • November 2023
  • 130 Pages
  • Global
From
Metabolic Syndrome Market (2023 Edition): Analysis By Indication (NASH, IRS, Hypercholesterolemia, Obesity Syndrome, Others), By Molecule Type, Route of Administration, By Region, By Country: Market Insights and Forecast (2018-2028) - Product Thumbnail Image

Metabolic Syndrome Market (2023 Edition): Analysis By Indication (NASH, IRS, Hypercholesterolemia, Obesity Syndrome, Others), By Molecule Type, Route of Administration, By Region, By Country: Market Insights and Forecast (2018-2028)

  • Report
  • June 2023
  • 270 Pages
  • Global
From
Japan Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis - Product Thumbnail Image

Japan Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis

  • Report
  • March 2023
  • 130 Pages
  • Japan
From
Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis - Product Thumbnail Image

Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

  • Report
  • March 2023
  • 190 Pages
  • Germany
From
Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis - Product Thumbnail Image

Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

  • Report
  • March 2023
  • 190 Pages
  • Switzerland
From
France Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis - Product Thumbnail Image

France Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis

  • Report
  • February 2023
  • 130 Pages
  • France
From
Canada Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis - Product Thumbnail Image

Canada Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis

  • Report
  • February 2023
  • 130 Pages
  • Canada
From
Israel Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis - Product Thumbnail Image

Israel Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis

  • Report
  • February 2023
  • 120 Pages
  • Israel
From
The Netherlands Diabetes Market, by Blood Glucose (SMBG) Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast - Product Thumbnail Image

The Netherlands Diabetes Market, by Blood Glucose (SMBG) Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast

  • Report
  • September 2020
  • 168 Pages
  • Netherlands
From
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more